Biofrontera Inc. (BFRI) income statement
BFRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$0.60+0.01 (+1.10%)
Close on Nov 18, 2026Market cap $8.91MP/E –Yield –
Biofrontera Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -14.2%
- Net margin
- -13.8%
- Return on equity, FY2025
- -141.3%
Financial strength
- Current ratio
- 1.18
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 44.2%
Valuation
- P/E ratio
- –
- Price to sales
- 0.19
- Price to book
- 1.50
- Dividend yield
- –
See a number that looks wrong?